| Andrew G Eichler, DO | |
|
707 N Emerson Ave, Wenatchee, WA 98801-2032 | |
| (509) 663-8711 | |
| Not Available |
| Full Name | Andrew G Eichler |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 707 N Emerson Ave, Wenatchee, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003847757 | NPI | - | NPPES |
| 8192445 | Medicaid | WA | |
| 108089 | Other | WA | L&I |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | OP00001092 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Andrew G Eichler, DO 820 N Chelan Ave, Wenatchee, WA 98801-2028 Ph: () - | Andrew G Eichler, DO 707 N Emerson Ave, Wenatchee, WA 98801-2032 Ph: (509) 663-8711 |
News Archive
The U.S. Food and Drug Administration has announced that it is requiring manufacturers to put a Boxed Warning on the prescribing information for the smoking cessation drugs Chantix (varenicline) and Zyban (bupropion). The warning will highlight the risk of serious mental health events including changes in behavior, depressed mood, hostility, and suicidal thoughts when taking these drugs.
Johnson & Johnson today announced sales of $16.6 billion for the second quarter of 2011, an increase of 8.3% as compared to the second quarter of 2010.
Talaris Institute, a nonprofit organization in Seattle, Washington, is proud to announce the launch of the new online service for parents of children birth to five – www.ParentingCounts.org. After nearly a decade of analyzing research and millions of dollars spent developing factual and practical content for parents, Talaris Institute introduced the Parenting Counts Center in November 2009 as a source of research-based information about child development with an exclusive birth-to-five developmental timeline.
GE Healthcare, a unit of the General Electric Company, today presented interim phase 2 study results of fluciclatide, in collaboration with the National Cancer Institute, a federal research agency and part of the National Institutes of Health. Fluciclatide is an integrin-targeted radiopharmaceutical under development for oncology PET imaging.
Two new studies analyzing treatment decisions in late-stage amyotrophic lateral sclerosis (ALS) patients shed light onto treatments aimed to extend the duration and quality of life in this progressively debilitating neuromuscular disorder.
› Verified 6 days ago
Carolyn R Johnson, ARNP Family Medicine Medicare: Medicare Enrolled Practice Location: 600 Orondo Ave, Ste 1, Wenatchee, WA 98801 Phone: 509-662-6000 Fax: 509-664-4588 | |
Richard J Beukema, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 Orondo Ave 1, Wenatchee, WA 98801 Phone: 509-662-6000 Fax: 509-664-4590 | |
Donald R Murphy, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711 | |
Patricia Ortiz, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711 | |
Dr. Scott E Lamb, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 Orondo Ave, Ste 1, Wenatchee, WA 98801 Phone: 509-662-6000 Fax: 509-664-4588 | |
Sara J. Norris, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 Orondo Ave, Wenatchee, WA 98801 Phone: 509-662-6000 |